PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1401349
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1401349
Global Artificial Intelligence in Cancer Diagnostics Market is valued at approximately USD 137.8 million in 2022 and is anticipated to grow with a healthy growth rate of more than 26.3% over the forecast period 2023-2030. Artificial Intelligence in Cancer Diagnostics refers to applying AI algorithms to analyze the medical data of users to detect cancer and help in treating it at an early stage. The Artificial Intelligence in Cancer Diagnostics Market is expanding because of factors such as a rise in healthcare expenditure, an increase in popularity for early detection of diseases and a shortage of healthcare professionals. However, data protection concerns of people using the technology and data inconsistency and flaws in the algorithm of AI tend to lower the market growth.
The rise in health care expenditure is a factor driving Artificial Intelligence In Cancer Diagnostics Market . According to health affairs 2023, health expenditures are predicted to grow 5.4%, in 2022-31 and to account for roughly 20% of the economy by the end of that period. The increase in popularity for early detection of diseases is another driving this market as people are now more concerned about their health and they want to detect every disease at an early stage as early detection of disease leads to easy and fast treatment of that disease moreover shortage of health care professionals has led the AI market to grow in the health care sector. An increase in cancer cases is an opportunity for this market to grow as according to Cancer Research UK 2023 it is estimated that there be 28 million new cancer cases globally each year by 2040. Another opportunity for this market to expand is a rise in technological advancement according to Statista 2023, in 2022, spending on digital transformation is estimated to reach USD 1.6 trillion. By 2026, global digital transformation spending is forecast to reach USD 3.4 trillion.
The key regions considered for the Global Artificial Intelligence in Cancer Diagnostics Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the rise in the advancement of technology in the healthcare sector, the presence of market players in this region and growing cancer cases coupled with growing digital transformation has led to the growth of the market in this region. Asia Pacific is expected to grow significantly over the forecast period, owing to factors such as government initiatives in the healthcare sector and the rise in popularity of AI-based cancer diagnostic technologies.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of tables and figures and dummy in nature, final lists may vary in the final deliverable